NEI Research News

Northwestern study finds ‘alarming’ disparities — lack of glaucoma care can lead to blindness.

UConn scientists find protein that stimulates regrowth of optic nerve cells.

Ribosomal protein genes that are found at low levels in adult nerve cells may be very important to axon regeneration.

Scientists find association between lipid metabolism and glaucoma.

UConn School of Medicine researchers report that a small population of nerve cells exist in everyone that could be coaxed to regrow, potentially restoring sight and movement after injury.

Indiana University researchers have identified a new therapeutic target that could lead to more effective treatment of glaucoma.

Researchers say findings reveal potential glaucoma drugs targets.

A 28-patient phase 1 gene therapy clinical trial for the degenerative retinal disease Leber hereditary optic neuropathy (LHON) found no significant safety concerns; however, treatment failed to improve or slow vision loss, with even the highest dose.

Two translational studies at the Vanderbilt Eye Institute are targeting photoreceptors and retinal ganglion cells (RGCs) to restore vision through regeneration of the retina. The research is funded by the NEI Audacious Goals Initiative.

A study by researchers at Washington University School of Medicine in St. Louis and Stanford University School of Medicine shows that the normal day-to-day activity of neurons can drive the formation and growth of brain tumors.